P. Preti
About
In The Last Decade
P. Preti
23 papers receiving 334 citations
Peers
Comparison fields: 5 of 73
- Oncology 161
- Pulmonary and Respiratory Medicine 116
- Hematology 104
- Molecular Biology 65
- Genetics 51
Countries citing papers authored by P. Preti
This map shows the geographic impact of P. Preti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Preti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Preti more than expected).
Fields of papers citing papers by P. Preti
This network shows the impact of papers produced by P. Preti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Preti. The network helps show where P. Preti may publish in the future.
Co-authorship network of co-authors of P. Preti
This figure shows the co-authorship network connecting the top 25 collaborators of P. Preti. A scholar is included among the top collaborators of P. Preti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Preti. P. Preti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 61 | |
| 2 | 33 | |
| 3 | 1 | |
| 4 | 153Sm-EDTMP radionuclide treatment of bony metastatic disease: a radiation protection evaluation. | 1 |
| 5 | 1 | |
| 6 | 25 | |
| 7 | Hematopoietic stem cells from different sources: biological and technical aspects. | 5 |
| 8 | 13 | |
| 9 | Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells. | 19 |
| 10 | Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donors. | 12 |
| 11 | Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer. | 14 |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 4 | |
| 15 | 4 | |
| 16 | [A case of congenital bilateral hip luxation in Ehlers-Danlos syndrome]. | 3 |
| 17 | [Baker's operation in the treatment of equinus deformity caused by cerebral palsy]. | 2 |
| 18 | Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors. | 1 |
| 19 | An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer. | 4 |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.